First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's DiseaseAna Martı́nez, Francisco J. Moreno, Mercedes Alonso et al.|Journal of Medicinal Chemistry|2002Cited by 448
SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives: Exploration of Structural Requirements for Glycogen Synthase Kinase 3 InhibitorsAna Martı́nez, Francisco J. Moreno, F. Javier Luque et al.|Journal of Medicinal Chemistry|2005Cited by 128
Thienyl and Phenyl α-Halomethyl Ketones: New Inhibitors of Glycogen Synthase Kinase (GSK-3β) from a Library of Compound SearchingSantiago Conde, Francisco J. Moreno, Daniel I. Pérez et al.|Journal of Medicinal Chemistry|2003Cited by 99
Non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: Study of structural requirements for thiadiazolidinone derivativesAna Castro, Ana Martı́nez, Concepción Pérez et al.|Bioorganic & Medicinal Chemistry|2007Cited by 57
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological toolsDaniel I. Pérez, Ana Martı́nez, Santiago Conde et al.|Bioorganic & Medicinal Chemistry|2009Cited by 57